Advertisement
Men prepared through group education report better urinary function outcomes
Study adds to guidance for urologists
Biological potential of disease better informs AS candidacy
Fostering collaboration between basic, translational scientists and clinicians
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
13-year retrospective shows evolution of treatment for aggressive disease
New evidence supports ART, but caveats remain
The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)
Negative affect reported in several sexuality-related functions at two years
Milestone studies advance understanding and treatment of prostate cancer
An oncologist discusses screening, diagnosis
Advertisement
Advertisement